Gem Investment Advisors’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18M Buy
1,434,476
+1,320,740
+1,161% +$12M 11.06% 3
2026
Q1
$804K Sell
113,736
-32,079
-22% -$226K 0.79% 22
2025
Q4
$722K Buy
+145,815
New +$615K 0.68% 23

Other funds holding DRTS

Gem Investment Advisors's DRTS Position: Q2 2026 in Review

Gem Investment Advisors increased its Alpha Tau Medical (DRTS) stake by 1,161% in Q2 2026, buying an estimated $12M and bringing the position to 1,434,476 shares worth $18M. The position accounts for 11.06% of the portfolio, ranked #3.

Gem Investment Advisors first reported a position in DRTS in Q4 2025 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Gem Investment Advisors held 1,434,476 shares of Alpha Tau Medical worth $18M as of Q2 2026.
  • Gem Investment Advisors bought 1,320,740 Alpha Tau Medical shares in Q2 2026, an estimated $12M.
  • Alpha Tau Medical made up 11.06% of Gem Investment Advisors's portfolio in Q2 2026, its #3 holding.
  • Gem Investment Advisors first reported a position in Alpha Tau Medical in Q4 2025 and has held it in 3 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Gem Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.